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Abstract 
Background and aims:  Addictive behaviours are among the greatest scourges on 
humankind. It is important to estimate the extent of the problem globally and in different 
geographical regions. Such estimates are available but there is a need to collate and 
evaluate these to arrive at the best available synthetic figures. Addiction has commissioned 
this paper as the first of a series attempting to do this. 
 
Methods: Online sources of global, regional and national information on prevalence and 
major harms relating to alcohol use, tobacco use, unsanctioned psychoactive drug use and 
gambling were identified through expert review and assessed. The primary data sources 
located were the websites of the World Health Organization (WHO), the United Nations 
Office on Drugs and Crime (UNODC) and the Alberta Gambling Research Institute. 
Summary statistics were compared with recent publications on the global epidemiology of 
addictive behaviours. 
 
Results: An estimated 4.9% of the world’s adult population (240 million people) suffer from 
alcohol use disorder (7.8% of men and 1.5% of women) with alcohol causing an estimated 
257 disability adjusted life years lost per 100,000 population. An estimated 22.5% of adults 
in the world (one billion people) smoke tobacco products (32.0% of men and 7.0% of 
women).  It is estimated that 11% of deaths in males and 6% of deaths in females each year 
are due to tobacco. Of ‘unsanctioned psychoactive drugs’, cannabis is the most prevalent at 
3.5% globally with each of the others at <1%; 0.3% of the world’s adult population (15 million 
people) inject drugs.  Use of unsanctioned psychoactive drugs accounts for an estimated 83 
disability adjusted life years lost per 100,000 population. Global estimates of problem 
gambling are not possible but in countries where it has been assessed the prevalence is 
estimated at 1.5%.  
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Conclusions: Tobacco and alcohol use are by far the most prevalent addictive behaviours 
and cause the large majority of the harm. However, the quality of data on prevalence and 
addiction-related harms is mostly low and comparisons between countries and regions must 
be viewed with caution. There is an urgent need to review the quality of data on which global 
estimates are made and co-ordinate efforts to arrive at a more consistent approach. 
Introduction 
Addictive behaviours (primarily alcohol consumption, tobacco smoking, and unsanctioned 
psychoactive drug use1) are major contributors to the global burden of morbidity and 
premature death (1). Problem gambling also incurs significant societal and individual costs 
(2). Addictive behaviours impose a high economic burden on society through healthcare 
costs, public safety, crime and lost productivity as well as other social costs (3). It is 
important to be able to have readily available, up-to-date prevalence and other estimates 
relating to these behaviours at a global, regional and national level to track progress towards 
reducing this burden, to help set policy priorities, and to help evaluate policies.  
 
Information of this kind is available, but two main factors limit its usefulness. First, alcohol, 
tobacco, other drug use and gambling are usually addressed separately, making it 
problematic to gain an overview of addictive behaviours as a whole. Secondly, data are of 
variable quality and it is not clear which figures are most accurate and comparable across 
countries. 
 
Addiction has commissioned this article as the first in what is intended to be a series on 
global statistics on addictive behaviours. This article is both a commentary on online sources 
of information on the prevalence and harms of addictive behaviours, and an overview of the 
current status of addictive behaviours globally. It is intended that future articles will update 
and expand the scope of the statistics that are collated, and the analyses undertaken.  
Aims 
(1) To identify major online, publicly accessible sources of data on addictive behaviours; (2) 
to use these to provide the best available estimates of global and regional prevalence of 
addictive behaviours (alcohol consumption, tobacco smoking, unsanctioned use of 
psychoactive drugs and gambling) and related harms; (3) to provide an expert review of the 
quality of the data available.  
Methods 
Online sources of information were identified through expert review and web searches. 
Major sources of global and regional information were assessed, along with national-level 
information for countries known to have systems for monitoring addictive behaviours. The 
strengths and limitations of the online sources identified were assessed and compiled as a 
commentary on available online information. The websites of the World Health Organization 
(WHO) and United Nations Office on Drugs and Crime (UNODC) provide the most 
comprehensive data on addictive behaviours globally, both as downloadable datasets and 
through regular publications. The data compiled in this report were obtained primarily from 
these sites. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) provided other sources of 
information (the latter primarily for the European region). 
 
Available country-level estimates of the prevalence of, and major harms associated with 
alcohol consumption and tobacco smoking were downloaded from the WHO website, and 
                                                          
1
 We use the term ‘unsanctioned psychoactive drug use’ to refer to use of psychoactive drugs whose 
possession and/or supply is illegal in most jurisdictions or prescription medications (primarily opioids) 
that are being used in an unsanctioned way. In this first article we do not consider ‘legal highs’ or 
caffeine. Neither do we consider products that are largely restricted to particular regions such as khat. 
As more data become available for these, they may be added to future articles in this series. 
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estimates of unsanctioned use of psychoactive drugs were downloaded from the UNODC 
website. The data selected related to the prevalence of use, and of harms related to use of 
alcohol, tobacco and unsanctioned drug use as the outcomes of primary relevance to 
assessment of the public health implications of addictive behaviours. Information on 
regulatory responses to alcohol and tobacco are available, but this aspect was not 
considered. 
 
Country-level data were imported into Microsoft Excel 2010, and codes to identify 
geographic region and economic status were added. Geographic regions were based on a 
listing from the United Nations Statistics Division 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#ftnb). Regions were then combined 
so as to give an acceptable number of countries on which data were available in each 
regional group, whilst maintaining appropriate country associations. (Note: the WHO 
identifies geographic regions differently from the United Nations.) The list of least developed 
countries from the United Nations Statistics Division was the basis of the identification of 
economic status of countries as “least developed” or “other”. The country level data are 
available as supplementary files [Link to supplementary files here]. 
 
Data were sorted by the codes indicating geographic or economic status grouping. For each 
indicator median, first and third quartile values were calculated. The nature of the data 
(much of the country-level data were age standardised) and missing data prevented 
calculation of weighted means or confidence intervals. Median values, with first and third 
quartile values to provide an indication of the range, were selected as appropriate measures 
of central tendency without distortions from extreme values. Global estimates presented are 
median values, with first and third quartile values, for all countries with data. 
 
Data on the prevalence of gambling were obtained from the website of the Alberta Gambling 
Research Institute (http://www.abgamblinginstitute.ualberta.ca/). As data on gambling are 
available from relatively few countries, these data are summarised in the text without further 
analysis. 
Results 
Online sources of information 
Table 1 describes and comments on the online sources of information that were used. 
 
[Table 1 near here] 
 
For some countries, more up-to-date and accurate information is available, either from 
national statistical websites or publications. It was beyond the scope of this article to 
investigate and document resources for all countries worldwide, but some sources for major 
English-speaking countries are summarised in the Table 2. In addition, differences in 
methodology for these national surveys make cross-national comparisons problematic. The 
population survey data from individual countries are likely to be the basis of information 
reported to the WHO and UNODC and incorporated into their datasets, but this is difficult to 
determine. 
 
[Table 2 near here] 
Summary data on prevalence of use and harms 
The figures need to be considered as broad estimates because of variation in methodologies 
and recency of surveys. In addition, it is important to note that part of the between-country 
differences will be due to wide variation in the age distribution of their populations. 
4 
 
Alcohol 
Summary data on the prevalence of alcohol consumption, potentially harmful levels of 
consumption, and harms attributed to alcohol are shown in Table 3. These data are obtained 
from the WHO website (the Global Information System on Alcohol and Health), with details 
indicated in the footnotes to Table 3. 
 
[Table 3 near here] 
 
The column “Prevalence of consumption” indicates the proportion of adults (aged 15 years 
or more) who consumed any alcohol in the previous 12 months, by gender and for the total 
adult population. From these data it is estimated that around 43% of adults globally (around 
2.1 billion people) drink alcohol (Table 3). There is considerable regional variation, from 
9.8% in Central, Southern and Western Asia, to 88.2% in Western Europe. In all regions 
drinking is less prevalent among females compared with males. Alcohol consumption is also 
less prevalent in the group of least developed countries compared with countries not listed in 
this group. 
 
Of this population of adults who consumed any alcohol in the previous 12 months, the 
proportion with heavy episodic drinking in the past 30 days is presented, also broken down 
by gender. Heavy episodic drinking is defined as consumption of at least 60 grams or more 
of alcohol on at least one occasion. This level of consumption would be expected to result in 
significant intoxication and is a pattern of drinking most likely to be associated with injury, 
including that arising from motor vehicle accidents and violent behaviour. Globally, around 
13% of people who drink alcohol have heavy episodic consumption. Again there is regional 
variation in this indicator, and heavy episodic drinking is more common amongst males 
compared with females, and less common in the group of least developed countries.  
 
The average per capita consumption of alcohol (in litres per person per year) is given 
because the volume of alcohol consumed is a determinant of alcohol-related harm (4). The 
average annual per capita consumption of alcohol follows the same pattern as the 
prevalence of consumption and the prevalence of heavy episodic drinking: globally alcohol 
consumption is a median of 6.5 litres per person per year. 
 
Disability-Adjusted Life Years (DALYs) provide an approach to estimating the impact of 
health conditions and injuries by combining estimates of premature mortality and years lived 
with disability (5). The data on DALYs associated with alcohol use are derived from 
substantial international work. As shown in Table 3, globally around 257 DALYs per 100,000 
population can be attributed to alcohol use disorders (2,570 per million), with regional 
estimates ranging from 97 per 100,000 population in Africa, to 727 per 100,000 population in 
Northern Europe. As with other data, the DALY estimates show that alcohol has less impact 
in the group of least developed compared with other countries. 
 
People with alcohol use disorders are most likely to be consuming alcohol in large quantities 
over extended periods of time and constitute a subgroup of the population most likely to 
experience harmful effects from alcohol. Alcohol use disorders in themselves can be 
considered a harmful effect of alcohol consumption. Alcohol use disorders comprise both 
harmful use and dependence. An estimated 4.9% of the world’s adult population (around 
240 million people) suffered from alcohol use disorders in the previous 12 months (Table 3). 
As with alcohol consumption, alcohol use disorders are more prevalent amongst males 
(7.8% globally compared with 1.5% in females). 
Tobacco 
Summary data on the prevalence of tobacco smoking, and deaths attributed to tobacco, are 
given in Table 4.  These data are derived from the WHO website (the Global Health 
Observatory), with specific sources indicated in the footnotes to Table 4. 
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[Table 4 near here] 
 
Any level of tobacco smoking is associated with a risk of harmful effects. Hence Table 4 
reports current smoking of any tobacco product as a proportion of the adult population aged 
15 and over without distinguishing between the frequency of use. Data for the youth 
population (aged 13-15) are a little different in that “use of tobacco” includes smokeless or 
smoking tobacco. The prevalence of tobacco use in the youth population is an indication of 
likely trends in smoking amongst the adult population as this cohort of youth becomes older.  
Around 23% of adults globally smoke tobacco, equating to around one billion people. While 
there is regional variation, the extent of this variation is less than is the case with alcohol, 
with the prevalence of tobacco smoking among adults ranging from a median of 13% in 
Africa, the Caribbean, Central and Northern America, to 29.5% in Oceania. Like alcohol 
consumption, tobacco smoking is less prevalent among females (7% compared with 32% for 
males). Compared with alcohol, there is less difference in the prevalence of tobacco 
smoking in the group of least developed countries (14%) compared with other countries 
(23%).  
 
The final columns of Table 4 give the proportion of deaths in 2004 (the most recent year for 
which this kind of figure is available) that were attributable to tobacco, by gender: a median 
of 6% (1st quartile 2.0%, 3rd quartile 10.0%) for females and a median of 11% (1st quartile 
4.0%, 3rd quartile 22.0%) for males.  
 
Data on DALYs attributable to tobacco smoking at a country level were not available when 
this review was compiled. Such estimates at a global level have been made by the Global 
Burden of Diseases project (1)and are considered in the discussion.  
Unsanctioned psychoactive drug use 
Data on unsanctioned drug use are limited. This is likely to be due in part to the illicit status 
of many drugs making it harder to monitor use, and in part to low prevalence reducing the 
capacity of surveys to accurately determine use. The limitations are apparent from Table 5 
where a number of regional measures were unable to be calculated due to missing data. 
 
[Table 5 near here] 
 
The data in Table 5 on the prevalence of unsanctioned drug use were drawn from the World 
Drug Report 2014 (6). For some countries data were available on the use of “opiates” 
(heroin, opium) and the use of prescription opioid drugs, but the number of countries for 
which data on these subsets of opioid drugs were reported were insufficient for meaningful 
analysis. Table 5 therefore reports only a single category of opioid-type drugs which would 
include use of illicit preparations (heroin, opium) and non-medical use of prescription 
preparations.  
 
Cannabis is the most prevalent drug that is mainly subject to unsanctioned use, followed by 
cocaine-type and amphetamine-type stimulants. Globally, approximately 3.5% of adults (174 
million people) use cannabis, with use most prevalent in Oceania (10.3% of adults). Other 
drugs included in Table 5 are used by less than 1% of the adult population. 
 
As indicated in Table 5, around 0.3% of the world’s adult population (15 million people) inject 
psychoactive drugs. One of the major harmful effects of unsanctioned drug use is the 
transmission of blood-borne viruses through injecting drug use. Hence data on the 
prevalence of HIV infection in the general population, the prevalence of injecting drug use, 
and the prevalence of HIV and Hepatitis C amongst injecting drug users are included in 
Table 5. These data were obtained from the World Drug Report and the WHO Global Health 
Observatory, as indicated in the footnotes to Table 5. The dates on which estimates of HIV 
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and hepatitis C estimates were made were highly variable. Because injecting drug use is a 
very efficient means of transmission of blood-borne viruses, epidemics of HIV and hepatitis 
C can develop amongst people who inject drugs very quickly. The extent to which these data 
reflect the current situation is unclear.  
 
Finally, Table 5 includes drug-related DALYs, which accounts for aspects such as episodes 
of psychosis and schizophrenia associated with use of cannabis and amphetamines, and 
drug-related deaths. Unsanctioned psychoactive drug use accounts for an estimated 83 
DALYs and 17.3 deaths per million population aged 15-64. 
Gambling 
Based on the listing of gambling studies from the Alberta Gambling Research Institute 
(http://www.abgamblinginstitute.ualberta.ca/LibraryResources/ReferenceSources/Prevalenc
eInternational.aspx), the median (1st quartile, 3rd quartile) proportion of the adult population 
who engaged in some form of gambling (other than buying raffle tickets) in the past year was 
65.3% (54%, 75%). “Problem gambling” (the definition of which is variable but generally 
reflects some loss of control over gambling) is much less prevalent at 1.5% (0.9%, 2.8%) of 
the adult population (Table 6).  
 
[Table 6 near here] 
Discussion 
Data limitations 
The most comprehensive data on addictive behaviours relate to alcohol and tobacco. Data 
on unsanctioned drug use are more sparse, reflecting the challenges of estimating the 
prevalence of a behaviour that tends to be hidden due to its largely illicit nature. There may 
be variation across countries in individuals’ willingness to divulge or report personal drug 
use. Only use of cannabis is sufficiently prevalent to be detected with confidence in 
household surveys across diverse countries, but of course under-reporting may still occur. 
Multiple sources of information, including data on seizures of illicit drugs, are generally 
required to gain a picture of trends in unsanctioned drug use. This is the approach taken by 
the UNODC in compiling the World Drug Report (6). Limitations in the extent of data on 
unsanctioned drug use and dependence globally have been noted by others (7). Data on 
problem gambling are only available for a minority of countries but they do include major 
populations of interest, including North America and much of Europe. 
 
While there is substantial information available on the internet about the prevalence of 
addictive behaviours and related harms, this information is scattered over multiple sites, and 
multiple locations within complex websites, such as that of the World Health Organization. 
Changes to the structure of websites are common further complicating regular monitoring of 
this information. Indeed, the scattered nature of the information is one reason for including 
summary data in this review. 
 
It is even more difficult to find information about the means of collection of data, dates of 
collection, and any manipulations by the agency collating the data. Some of this information 
is available, but much is not, making it difficult to assess the validity or accuracy of data. 
Information is skewed towards countries with relatively good reporting capacity; very little 
data are available for much of Africa and some areas of Asia. In general it is very difficult to 
speak with confidence about addictive behaviours in developing countries. The globalised 
nature of addictive behaviours, and the capacity for rapid change in the modern world make 
it highly desirable for knowledge of global patterns of addiction to be better understood.  
Alcohol 
Much of the data in Table 3 is derived from the WHO Global survey on alcohol and health 
conducted in 2012 which resulted in responses from 176 countries. The survey is the basis 
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for the Global status report on alcohol and health 2014 (4) which presents a much more 
detailed analysis of this drug than was possible in this article. The WHO estimated that 
worldwide consumption in 2010 was equal to 6.2 litres of pure alcohol per person aged 15 
years or older, or 13.5 grams pf pure alcohol per person per day. This figure is consistent 
with the median value of 6.5 litres presented in Table 3. In the WHO report (4) it is further 
noted that a quarter of alcohol consumption (24.8%) was unrecorded, that is, homemade 
alcohol, illegally produced or sold outside normal government controls. Of total recorded 
alcohol consumed worldwide, 50.1% was consumed in the form of spirits. The WHO report 
also notes the substantial regional variation in the prevalence of alcohol consumption, and 
lower rates of drinking among females, along with the association between economic wealth 
of a country and higher per capita consumption of alcohol and greater prevalence of heavy 
episodic drinking among drinkers. 
 
We were unable to locate online data on deaths related to alcohol consumption, but in the 
WHO Global status report on alcohol and health 2014 (4) it was estimated that in 2012, 
about 3.3 million deaths, or 5.9% of all global deaths, were attributable to alcohol 
consumption, 7.6% of deaths among males and 4.0% of deaths among females.  
 
Estimates of Disability-Adjusted Life Years (DALYs) attributed to alcohol use disorders are 
listed in Table 3; the WHO Report estimated that in 2012, 5.1% of the global burden of 
disease and injury were attributable to alcohol consumption (4). The Global Burden of 
Diseases project similarly estimated that 5% of DALYs were attributable to alcohol use (1). 
The highest alcohol-attributable fractions of deaths and DALYs were reported in the WHO 
European Region. The data in Table 3 are consistent with this. Rehm et al. (8) note that 
most of the deaths caused by alcohol fall in the broad categories of injury, cancer, 
cardiovascular disease, and liver cirrhosis.  
 
While alcohol has been argued to have some beneficial effects on cardiovascular diseases 
in older age groups at low levels of consumption, this remains highly contentious (9, 10) and 
the net effect of alcohol consumption on health is clearly detrimental. The costs associated 
with alcohol amount to more than 1% of the gross national product in high-income and 
middle-income countries, with the costs of social harm constituting a major proportion in 
addition to health costs (8).  
 
The data in Table 3 provide an estimate that 4.9% of adults globally have an alcohol use 
disorder (7.8% of men and 1.5% of females). The presence of an alcohol use disorder 
indicates increased risk of experiencing harm related to alcohol consumption. In a 
systematic review, Roerecke and Rehm (11) calculated a relative risk of mortality among 
clinical samples of men with an alcohol use disorder, compared to a control group, of 3.38 
(95% confidence interval 2.98-3.84); in women it was 4.57 (95% CI 3.86-5.42). Relative risks 
were markedly higher for those aged 40 or less (ninefold in men, 13-fold in women) while still 
being at least twofold higher among those aged 60 years or more. 
 
In 2010, alcohol use was one of the three leading risk factors for global disease burden (1). 
Tobacco 
The data in Table 4 provide an estimate that globally, 22.5% of adults (32% males, 7% 
females) currently smoke tobacco. Ng et al. (12) derived similar estimates of the prevalence 
of daily smoking using a modelling approach. Ng et al. estimated that age-standardised 
prevalence of daily tobacco smoking in 2012 to be 31.1% for men and 6.2% for women. 
These estimates are consistent with the median values obtained from the data summarised 
in Table 4.  
 
Tobacco smoking is less prevalent than alcohol consumption but the disease burden due to 
tobacco smoking is greater. Tobacco smoking (including second-hand smoke) is one of the 
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three leading risk factors for global disease burden, contributing 6.3% (uncertainty interval 
5.5-7.0%) of global DALYs in 2010 (1). 
 
Table 4 presents data on the proportion of deaths in 2004 that were attributable to tobacco 
smoking. The WHO global report: Mortality attributable to tobacco, 2012 (13) presents a 
more detailed analysis. This report notes that globally 12% of all deaths in 2004 among 
adults aged 30 years and over were attributable to tobacco, with regional estimates ranging 
from 3% in the African region (as defined by WHO) to 16% in the Americas and European 
regions. Globally, 5% of all deaths from communicable diseases, and 14% of all deaths from 
non-communicable diseases among adults aged 30 years and over are attributable to 
tobacco. Within communicable diseases, tobacco use is responsible for an estimated 7% of 
all deaths due to tuberculosis and 12% of deaths due to lower respiratory infections. Within 
non-communicable diseases, in a given year tobacco use is responsible for 10% of all 
deaths from cardiovascular diseases, 22% of all cancer deaths, and 36% of all deaths from 
diseases of the respiratory system. The additional risk of death from cardiovascular system 
resulting from tobacco use was more likely among younger adults (13).  
Unsanctioned psychoactive drug use 
Available data from the World Drug Report (6) that are the basis of Table 5, provide only the 
prevalence of unsanctioned drug use; the prevalence of injecting drug use is included as an 
indicator of problematic use, but the World Drug Report does not provide the prevalence of 
drug dependence. 
  
Multiple systematic reviews of unsanctioned drug use were undertaken for the Global 
Burden of Disease (GBD) project. Based on this work, Degenhardt et al. (7) noted that there 
is qualitative evidence of unsanctioned drug use and dependence for most countries, but 
there are gaps in the estimates of prevalence of use. Levels of unsanctioned drug use seem 
to be highest in high-income countries and in countries near major drug production areas, 
but data for their use in low-income countries are poor (14). Degenhardt et al. (15) note that, 
globally, drug use is not distributed evenly and is not simply related to drug policy, since 
countries with stringent user-level illegal drug policies did not have lower levels of use than 
countries with more liberal policies. 
 
Work for the GBD project located estimates of the prevalence of use in 77 countries for 
amphetamine-type stimulants, 95 for cannabis, 86 for cocaine and 89 for opioids. However, 
dependence prevalence estimates were located in very few countries: 9 for amphetamine-
type stimulants, 7 for cannabis, 5 for cocaine and 25 for opioid drugs (7). Following 
modelling and imputation of missing data, it was estimated that opioid and amphetamine 
dependence were the most common forms of unsanctioned drug use that involved 
dependence in 2010. Although cannabis is by far the most commonly used unsanctioned 
drug worldwide, the prevalence of cannabis dependence was lower than that for 
amphetamine-type stimulants and opioid drugs (7). Estimates of prevalence of amphetamine 
dependence were highest for Southeast Asia and Australasia; estimates of the prevalence of 
cocaine dependence were highest for North America High-Income and Latin America. 
Australasia had among the highest levels of reported opioid dependence, although the 
largest populations were in East and South Asia (16, 17).  Where estimates were available, 
most individuals dependent on drugs were male (64% each for cannabis and amphetamine-
type stimulants and 70% each for opioids and cocaine) (18). 
 
Globally, it is estimated that in 2012, between 3.5 and 9.0% of the world population aged 15-
64 had used a psychoactive drug, other than alcohol or tobacco, in an unsanctioned way at 
least once in the previous year.  
 
Drug use disorders account for 0.8% of global all-cause DALYs. Globally, unsanctioned drug 
use was identified by the GBD 2010 study as the eighth largest contributor to disability in 
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males (18). Drug dependence and disease burden are highest in the 20-29 year age group 
(18). Two-thirds (69.3%) of all drug disorder DALYs were explained by years lived with 
disability and 30.7% by years of life lost. Whilst opiate use (e.g. opium and heroin) has 
remained relatively stable in recent years, misuse of pharmaceutical opioids is increasing 
and opioid dependence is the greatest contributor to illicit drug burden, accounting for 46% 
(17). This finding is attributable to the substantial contribution of opioid drug use to 
premature mortality, the high disability weight, and the comparatively large population of 
dependent opioid users.  
 
The DALY estimates for opioid drug use were around eight times those for cocaine 
dependence, and 4.5 times those for cannabis dependence (18). In a systematic review 
undertaken for the GBD 2010, Degenhardt et al. (19) estimated the point prevalence of 
cannabis dependence globally at 0.19% (95% uncertainty 0.17-0.21%). Prevalence peaked 
between 20-24 years, was higher in males (0.23%, 95% uncertainty 0.2-0.27%) than 
females (0.14%, 95% uncertainty 0.12-0.16%) and in high income regions. Cannabis 
dependence accounted for 0.08% of DALYs globally. 
 
Demand for treatment, and the types of substances being used by people entering 
treatment, provide additional information on the prevalence of problematic drug use. The 
World Health Organization has established a database of information on treatment demand 
and provision of services for substance use, but at present the available information is 
limited and does not provide an accurate global picture of treatment. Detailed coverage of 
treatment services was beyond the scope of this review, but it is worth noting that the 
UNODC has recorded a noticeable increase in the number of persons seeking treatment for 
cannabis use disorders over the past decade, particularly in the Americas, Oceania and 
Europe. Furthermore, while opioid drugs are the most prevalent primary drug of abuse 
among those seeking treatment in Asia and in Europe, cocaine is the most prevalent in the 
Americas (6). Treatment is an important strategy in the reduction of harms due to substance 
use in people who are dependent. In this regard the UNODC notes a continuing gap in 
service provision with only one in six problem drug users globally having had access to or 
receiving drug dependence treatment services each year.  
 
Injecting drug use has a notable contribution to burden of disease by increasing the risk of 
infection with HIV and hepatitis C (18). In a systematic literature review, Mathers et al. (20) 
identified injecting drug use in 148 countries. They noted that data for the extent of injecting 
drug use was absent for many countries in Africa, the Middle East, and Latin America. The 
data have not improved since then, with only 83 countries providing data on the prevalence 
of injecting drug use for the World Drug Report 2014 (6). Mathers et al. (20) reported that the 
largest numbers of injectors were found in China, the USA and Russia, where mid-estimates 
of HIV prevalence among injectors were 12%, 16% and 37%, respectively. HIV prevalence 
among injecting drug users was 20-40% in five countries (3% of 148 countries identified with 
injecting drug use) and over 40% in nine countries (6%). Based on the data from the World 
Drug Report 2014, 10 countries (12% of those reporting injecting drug use) had HIV 
prevalence between 20 and 40%, and four (4.8% of countries reporting injecting drug use) 
had HIV prevalence greater than 40%.  
 
The UNODC, UNAIDS the World Bank and WHO jointly estimate that 0.27% (range 0.19-
0.48%) of the population aged 15-64 inject drugs. In Eastern and South-Eastern Europe the 
rate of injecting drug use is 4.6 times higher than the global average. It is estimated that an 
average of 13.1% of the total number of people who inject drugs are living with HIV, and 
more than half of the people who inject drugs are estimated to be living with hepatitis C (6). 
HIV/AIDS was one of the top six leading causes of death and of years of life lost due to 
premature mortality in 2010, although there was a small decline in deaths from HIV/AIDS 
compared to 2006 (21).  
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The UNODC in the World Drug Report 2014 (6) estimated drug-related mortality at 40.0 
(range 20.8-49.3) deaths per million aged 15-64. Compared with the general population, 
people who inject drugs have an elevated risk of death. Standardised mortality ratios (95% 
confidence interval) for people who inject drugs are estimated at 14.68 (13.01, 16.35) 
globally (22). Crude mortality rates were higher for males compared to females, but females 
who inject drugs had a much higher elevation in mortality relative to their age-matched peers 
in the general population than did males who inject drugs. Drug overdose and AIDS-related 
mortality were by far the most common causes of death (22). 
Gambling 
Insufficient data were located for a meaningful analysis of global prevalence of gambling and 
harms arising from gambling. Data are available for some countries of interest, however. 
Using a standard definition of problem gambling the prevalence appears to be low, at less 
than 2%. It is not possible to quantify the harms related to this using available data. 
Conclusion 
This article identifies and discusses a number of online databases that provide information 
on the global and regional status of addictive behaviours. Data on key indicators of 
relevance to public health are tabulated. There is relatively good information on the 
prevalence of use and harms associated with alcohol drinking and tobacco smoking, some 
information on the prevalence of unsanctioned drug use, and limited information on harms 
related to injecting drug use. However, there is almost no information on the prevalence of 
dependence on drugs used in an unsanctioned way, a gap that is significant given that it is 
dependence that primarily drives demand for treatment. Such data may be available at a 
country level, but the lack of global data leaves a knowledge gap that impedes the capacity 
for agencies such as WHO, UNODC and UNAIDS and international non-government 
organisations to plan their activities with a view to achieving the greatest possible impact. 
This suggests an important area of need for future effort and investment to improve the 
response to addiction worldwide. In particular it suggests an urgent need to review the 
quality of data on which global estimates are made and plan for a more consistent approach 
based on core indicators. The Lisbon consensus on key epidemiological indicators of drug 
use (http://www.unodc.org/documents/data-and-
analysis/statistics/Drugs/lisbon_consensus.pdf) and toolkits developed by the UNODC under 
the Global Assessment Programme on Drug Abuse (http://www.unodc.org/unodc/en/GAP/) 
provide a context for such work. 
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Table 1: Description of, and comments on, major online sources of global and regional 
information on addictive behaviours. 
Aspect Comment 
1. World Health Organization (www.who.int) 
Addictive 
behaviours 
covered 
Coverage is best for alcohol and tobacco, some information on burden of 
disease related to unsanctioned drug use, with links to information on HIV. 
Gambling is not monitored by WHO. 
Major reports  World Health Statistics: annual report with summary data on alcohol 
consumption and smoking as risk factors, and information on health 
systems. 
 WHO Report on the Global Tobacco Epidemic: periodic report focusing 
on the status of tobacco control policies on a global basis. 
 WHO Global Status Report on Alcohol and Health: published in 2011 
and 2014; summarises evidence on harms related to alcohol, global data 
on consumption and consequences, and policies and interventions. 
 ATLAS on substance use: single report published in 2010, this report 
summarises resources for the prevention and treatment of substance 
use disorders. 
 Global Health Risks: single report published in 2009, based on 2004 
data, provides information on 24 factors affecting health, with tobacco 
use, alcohol and illicit drugs considered as one risk category.  
 WHO Global Report, Mortality Attributable to Tobacco: single report 
published in 2012, based on 2004 data used for Global Health Risks 
report. 
Downloadabl
e data 
Global Health Observatory Data Repository, apps.who.int/gho/data Data on 
tobacco and alcohol. Tobacco control data reflects policies for prevention. 
Global Information System on Alcohol and Health – consumption, harms, 
patterns, economic aspects, control, prevention, youth. Data in table format; 
can be downloaded for manipulation or analysis. Available in seven 
languages. Data can also be retrieved by country.  
Strengths  A number of different maps, both static and interactive, are available, and 
can be reached through different links. The maps provide a quick visual 
overview of data and countries for which no data are available are clearly 
identified. 
 The WHO website is large, but the data and statistics pages are reached 
through multiple links. There are also links to other sites, such as 
UNAIDS, which provide relevant information. 
Limitations  Gaps in data: WHO relies on reports completed by member states. There 
are large gaps in data, particularly for countries in Africa. The gaps limit 
the extent to which analyses can be carried out relating strategies and 
programs to prevalence of substance use. 
 Age of data: WHO reports the latest available data, but it is often 
necessary to look at the detail to determine the age of the estimate, and 
gaps in data limit the extent to which analyses of trends can be 
undertaken. 
 Finding explanatory notes: Headings of maps and tables may not provide 
sufficient information to interpret the data reported, and the required 
information is not easily located. For example, graphs of the prevalence 
of alcohol use and substance use disorders do not provide the definition 
of “disorders”. Look for the Indicator Code Book as a particularly useful 
guide to the Global Information System on Alcohol and Health. 
2. United Nations Office on Drugs and Crime http://www.unodc.org 
Addictive Unsanctioned drug use only: the most comprehensive data are for opioid 
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Aspect Comment 
behaviours 
covered 
drugs, probably reflecting international treaties covering monitoring of drugs. 
Major report World Drug Report: published annually, this is the most comprehensive 
compilation of data on unsanctioned drug use globally. Main aspects 
covered are production, trafficking and consumption and the consequences 
of illicit drug use in terms of treatment, drug-related diseases and drug-
related deaths. Available in six languages. 
Downloadabl
e data 
UNODC Statistics (stats.unodc.org): look for the online tool for creating 
personalized reports. Available data includes, use, injecting, HIV and 
hepatitis, mortality, treatment demand, price, seizures. Tables are 
downloadable to pdf or Excel. 
Strengths Maps and tables: These are included in the World Drug Report but as they 
are large documents in themselves, it is useful to be able to download these 
as individual documents. Topics are prevalence in drug use, expert 
perceptions of trends, and illicit drugs as a source of demand for treatment. 
The format of tables downloaded from the World Drug Report is better for 
manipulation than tables from stats.unodc.org. 
Limitations Gaps in data and age of data: UNODC, like WHO, are dependent on the 
information reported by member States. Data on illicit drug use in Southern 
Asia and Middle East countries are particularly limited, with data either not 
being reported or in some cases being 10 years old or more. UNODC 
defines geographic regions differently to WHO and some countries are listed 
differently complicating the combination of data. 
3. UNAIDS www.unaids.org 
Addictive 
behaviours 
covered 
Included in our listing because of the significance of injecting drug use as a 
risk factor for transmission of HIV, however data on HIV rates amongst 
injecting drug users globally is more readily accessed from the UNODC 
website, and prevalence of HIV amongst the general population is available 
from the WHO website. 
Major reports Annual reports on global AIDS epidemic, covering epidemiology, prevention 
and treatment of HIV/AIDS: Coverage of injecting drug use is a minor 
component of the reports 
Downloadabl
e data 
AIDSinfo: Pre-set tables are downloadable to Excel 
Strengths Country reports that can be generated via tool located under “Know your 
epidemic”. A spreadsheet tool is available for calculating the estimated 
number of new infections based on local prevalence. 
Limitations  Gaps in data, capacity for analysis: As with all such information, 
coverage depends on what data is reported by member states. The site 
includes a number of tools for visualisation of data, but there is little 
capacity for analysis. 
 Site navigation: Navigation tools are not intuitive making the process of 
finding data on injecting drug use cumbersome. 
4. European Monitoring Centre for Drugs and Drug Addiction 
www.emcdda.europa.eu 
Addictive 
behaviours 
covered 
Unsanctioned drug use only (alcohol, tobacco, gambling not covered), and 
only for countries in the European Union. The “Countries” tab on the home 
page is a quick link to the list of countries included, as well as links to 
available topics. 
Major reports Annual report on the state of the drugs problem in Europe: main report for 
data on patterns of drug use in Europe. 
Downloadabl
e data 
Statistical Bulletin by year and country (emcdda.europa.eu/stats13): there is 
a facility to produce tables that can be downloaded and combined for 
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Aspect Comment 
analysis. A link to a help page gives comprehensive information and 
explanatory notes. Data topics include prevalence and population estimates, 
infectious diseases and deaths, treatment demand and health and social 
responses, and crime, seizures and market data. 
Strengths  Website design: Good use of tabs, banners and linked lists to help users 
find information on the site. The publications database offers multiple 
indexing methods for locating publications of interest. The topics tab on 
the home page links to a good listing of topics, with separate listing of 
“Topics in the spotlight”. The summaries of these issues, such as 
“Synthetic cannabinoids in Europe” are very good quality, often with 
interactive elements. 
 Maps and data sheets: Interactive maps are well presented, with clear 
links to data sheets and country notes that provide information, and 
cautions on limitations in data. 
 Drug profiles: Accessed from topics tab or quick links, the drug profiles 
provide good background information, and pictures, covering a wide 
range of drugs that are used for non-medical purposes. 
Limitations  Gaps and inconsistencies in data: Like WHO and UNODC, EMCDDA 
can only report the data that is provided by member states. 
 Data on opioid drugs: Population prevalence data covers cannabis, 
amphetamines, ecstasy and cocaine, not opioid drugs. Data on use of 
opioid drugs is included under “problem drug use”, which also covers 
injecting drug use. 
5. Alberta Gambling Research Institute (www.abgamblinginstitute.ualberta.ca)  
Addictive 
behaviours 
covered 
Gambling only 
Major reports Main relevant resource is listing of international studies examining the 
prevalence of problem gambling. Listing includes 80 separate studies in 30 
countries, mostly undertaken in the last decade. 
Downloadabl
e data 
Data from international gambling prevalence studies available as 
spreadsheet or pdf. (See 
http://www.abgamblinginstitute.ualberta.ca/LibraryResources/ReferenceSour
ces/PrevalenceInternational.aspx) 
Strengths Summary of international gambling prevalence studies. 
Limitations Studies of prevalence of gambling are available only for some developed 
countries. 
6. Global Tobacco Surveillance System (http://nccd.cdc.gov/GTSSData) 
Addictive 
behaviours 
covered 
Tobacco use, based on four global surveys (youth tobacco, school 
personnel, health professions students, and adults. 
Major reports Data from GTSS contributes to multiple publications; the website contains 
links to published research related to the survey material. 
Downloadabl
e data 
Data can be downloaded in various formats, based on the survey, region and 
country or location. 
Strengths Website design: multiple options for using data online, with easy links to 
download options. 
Limitations Surveys cover only tobacco use, with most data on tobacco smoking in the 
form of cigarettes, pipes and cigars.  
7. World Tobacco Atlas (www.TobaccoAtlas.org)  
Addictive 
behaviours 
covered 
Tobacco use, drawing on data from the WHO and United States Centers for 
Disease Control and Prevention (CDC) 
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Aspect Comment 
Major reports The Tobacco Atlas can be downloaded in pdf format, in multiple languages. 
Information from the Atlas is also available online as a series of topics. 
Downloadabl
e data 
No data files can be downloaded. Relevant data are more readily obtained 
from the WHO and CDC websites. 
Strengths Summary information in the topics pages on the website. 
Limitations The only addictive behaviour covered is tobacco use, and the data on the 
prevalence of tobacco use and related harms is several years old. 
8. Global Burden of Diseases (www.healthdata.org/gbd) 
Addictive 
behaviours 
covered 
Alcohol, tobacco, illicit drugs 
Major reports Links to range of journal articles and other publications on global burden of 
disease 
Downloadabl
e data 
Website has tool for selecting and downloading data. 
Strengths Information on wide range of different aspects of overall burden of disease 
that is useful for putting data on addictive behaviours into context for 
individual countries and regions. 
Limitations The same limitations on the availability of data, particularly on unsanctioned 
drug use, apply to the Global Burden of Diseases project. 
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Table 2: Listing of additional online sources of information for selected countries 
Source Type of information 
United Kingdom 
UK Health and Social Care Information Centre 
http://www.hscic.gov.uk/home 
Health and social care issues 
including alcohol consumption, 
reports on drug use among young 
people, data from surveys of 
secondary school pupils. 
Crime Survey for England and Wales 
www.crimesurvey.co.uk 
Reports from surveys of crime 
experienced by participants in the 
past year, including crimes that 
may not have been reported to 
police. Trafficking and possession 
of drugs are included, but the 
proportion of other crimes that 
may be drug-related is not 
reported.  
Public Health England 
https://www.gov.uk/government/organisations/public-
health-england 
Reports and data on treatment. 
National Drug Treatment Monitoring System 
http://www.nta.nhs.uk/uploads/annualdrugstatistics2012-
13-statisticalreport.pdf or www.ndtms.net 
Annual statistical reports on 
treatment. 
USA  
National Survey on Drug Use and Health (NSDUH) 
http://www.samhsa.gov/data/NSDUH.aspx 
National and state-level data on 
the use of tobacco, alcohol, 
unsanctioned drug use (including 
non-medical use of prescription 
drugs) and mental health among 
persons aged 12 and older in the 
United States. Survey data are 
available as reports, online 
analysis or downloadable 
datasets. 
Drug Abuse Warning Network (DAWN) 
http://www.samhsa.gov/data/DAWN.aspx 
Data from hospital emergency 
departments and drug-related 
deaths investigated by medical 
examiners and coroners 
National survey of substance abuse treatment services 
http://www.samhsa.gov/data/DASIS.aspx 
Information on treatment facilities 
TEDS, the treatment episode data set 
http://www.samhsa.gov/data/DASIS.aspx?qr=t#TEDS 
Information on treatment 
episodes 
Monitoring the Future 
http://www.monitoringthefuture.org/ 
A survey of 8th, 10th, and 12th 
grade students which has been 
undertaken since 1975 
Youth Risk Behavior Survey 
http://www.cdc.gov/HealthyYouth/yrbs/ 
A national school based survey in 
most US states, territories and 
some tribal schools, that includes 
questions on alcohol and drug 
use, tobacco use and HIV-related 
risk behaviours 
Australia 
National household surveys of alcohol and other drug Information on the surveys and 
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use http://www.aihw.gov.au/national-drugs-strategy-
household-surveys/ 
links to reports, other sources of 
information on treatment, and a 
link to the Australian data archive 
National survey of alcohol and tobacco use by 
secondary school students 
http://www.srcentre.com.au/news-events/news/news-
item/2012/12/10/australian-secondary-students-alcohol-
and-drug-survey 
Undertaken every three years. 
The link is for the most recent 
survey, undertaken in 2011. 
Illicit Drug Reporting System (IDRS) and Ecstasy and 
Related Drugs Reporting System (EDRS) 
http://ndarc.med.unsw.edu.au 
These projects use interviews 
with drug users and key 
informants to gain information on 
trends in unsanctioned drug use 
in Australia. 
Canada 
Canadian Alcohol and Drug Use Survey http://www.hc-
sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.php  
Links to data from all surveys – 
most recent survey undertaken in 
2012 
New Zealand 
New Zealand Alcohol and Drug Use Survey 
http://www.health.govt.nz/nz-health-statistics/national-
collections-and-surveys/surveys/current-recent-
surveys/alcohol-and-drug-use-survey  
Links to reports and data from 
2007/08 survey (the most recent 
undertaken). 
New Zealand Tobacco Use Survey 
http://www.health.govt.nz/nz-health-statistics/national-
collections-and-surveys/surveys/current-recent-
surveys/tobacco-use-survey  
Links to reports and data – most 
recent survey undertaken in 
2009. 
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Table 3: Alcohol consumption, by geographic region, economic status, and globally and indicators of harm related to alcohol use 
Region 
1
  
[Range of number of 
countries with data for 
each indicator] 
Prevalence of consumption, % in 
past 12 months 
2
 
Estimated litres per capita 
3
 Drinkers with heavy episodic 
consumption, % in past 30 days 
4
 
Prevalence of alcohol use disorders, 
% in past 12 months 
5
 
DALYS due to 
alcohol use 
disorders 
6
 
Male Female Total Male Female Total Male Female Total Male Female Total  
Africa [52-53] 42.0  
(15.2, 51.4) 
16.3 
(6.4, 28.8) 
30.0  
(11.1, 40.9) 
6.4  
(2.7, 11.3) 
1.6  
(0.4, 2.9) 
4.0  
(1.4, 7.0) 
15.4  
(5.9, 36.6) 
4.1 
(0.4, 17.3) 
11.8  
(4.6, 31.0) 
5.4  
(1.4, 8.8) 
0.7  
(0.1, 1.6) 
3.0  
(0.7, 5.2) 
97  
(57, 137) 
Caribbean, Central & 
Northern America [23] 
66.8   
(59.1, 70.3) 
43.4  
(35.9, 49.2) 
55.0  
(47.4, 59.8) 
9.8   
(7.7, 12.4) 
3.9  
(2.5, 4.7) 
6.8  
(5.2, 8.2) 
21.0  
(14.6, 31.9) 
6.0  
(3.0, 14.7) 
15.0  
(9.8, 24.5) 
8.0  
(7.8, 8.2) 
3.1  
(3.1, 3.2) 
5.6  
(5.4, 5.7) 
553  
(482, 600) 
South America [12] 69.6  
(62.5, 70.2) 
47.6  
(41.3, 49) 
58.2  
(51.8, 59.4) 
12.1  
(9.8, 13.4) 
4.2  
(3.6, 5.2) 
8.1  
(6.8, 8.9) 
18.1  
(13.5, 35.0) 
3.2  
(1.6, 10.8) 
13.2  
(8.2, 23.9) 
8.1  
(8.0, 8.4) 
3.1  
(3.1, 3.2) 
5.6  
(5.5, 5.7) 
582  
(465, 672) 
Central, Southern & 
Western Asia [30-31] 
13.9  
(7.5, 49.4) 
4.6  
(3.4, 15.0) 
9.8  
(5.8, 37.2) 
3.6  
(1.2, 7.3) 
0.4  
(0.1, 1.3) 
2.1  
(0.7, 4.3) 
3.1  
(0.8, 29.6) 
0.5  
(0.2, 2.6) 
2.3  
(0.6, 19.9) 
1.6  
(0.5, 8.1) 
0.3  
(0.1, 1.8) 
1.1  
(0.3, 4.9) 
146  
(58, 232) 
Eastern & South-Eastern 
Asia [16] 
48.5  
(19.6, 57.9) 
28.8  
(8.1, 33.9) 
38.4  
(14.6, 45.5) 
9.4  
(1.8, 12.0) 
1.0  
(0.1, 2.2) 
5.5  
(1.0, 7.1) 
9.6  
(4.4, 35.2) 
0.8  
(0.4, 5.3) 
6.6  
(2.9, 24.3) 
6.4  
(2.6, 8.8) 
0.9  
(0.5, 1.4) 
3.8  
(1.6, 4.8) 
280  
(130, 550) 
Eastern Europe [10] 73.8  
(72.7, 86.3) 
62.0  
(60.6, 72.7) 
67.7  
(66.2, 79.8) 
21.3  
(19.5, 24.4) 
7.2  
(6.0, 8.1) 
13.6  
(12.9, 15.5) 
50.0  
(32.1, 58.0) 
17.8  
(8.6, 27.9) 
32.5  
(23.9, 43.5) 
13.7  
(8.8, 30.1) 
2.4  
(1.5, 6.2) 
8.2  
(5.2, 17.7) 
707 
(447, 1137) 
Northern Europe [10] 74.7  
(73.7, 88.3) 
62.6  
(61.6, 79.4) 
68.4  
(67.1, 84.4) 
16.4  
(12.4, 18.1) 
6.6  
(5.2, 7.2) 
11.5  
(8.8, 12.3) 
44.4  
(40.9, 64.1) 
23.3  
(19.8, 33.7) 
34.7  
(31.9, 49.6) 
14.3  
(10.5, 17.8) 
3.5  
(3.1, 6.0) 
9.3  
(7.0, 11.5) 
727  
(504, 978) 
Southern Europe [12-13] 72.2  
(69.0, 73.4) 
58.5  
(46.4, 62.8) 
66.0  
(57.2, 68.0) 
14.6  
(10.4, 18.2) 
5.9  
(3.7, 7.1) 
10.3  
(7.0, 12.4) 
18.4  
(17.2, 35.2) 
2.7  
(2.3, 18.2) 
11.4  
(10.8, 27.7) 
8.8  
(6.8, 9.1) 
2.1  
(1.7, 2.5) 
5.5  
(4.3, 5.7) 
350  
(236, 418) 
Western Europe [7-8] 92.1  
(82.2, 95.0) 
83.6  
(78.5, 92.9) 
88.2  
(80.3, 93.9) 
15.4  
(15.0, 16.8) 
6.4  
(6.3, 7.1) 
11.0  
(10.3, 11.9) 
38.9  
(23.6, 56.5) 
14.1  
(7.6, 27.0) 
25.6  
(15.6, 41.7) 
9.4  
(9.1, 14.3) 
2.8  
(2.4, 3.4) 
6.1  
(5.8, 8.7) 
464 
(406, 514) 
Oceania [11-15] 50.3  
(44.2, 55.8) 
30.9  
(19.4, 34.7) 
34.6  
(31.8, 40.7) 
5.9  
(3.1, 13.2) 
0.6  
(0.4, 2.6) 
3.3  
(1.7, 7.9) 
35.8  
(20.9, 59.8) 
10.9  
(6.3, 18.0) 
26.4  
(13.0, 37.1) 
7.6  
(7.4, 7.6) 
1.4  
(1.4, 1.4) 
4.5  
(4.4, 4.6) 
248  
(161, 287) 
Least developed 
countries [46-47] 
34.1  
(12.4, 49.0) 
14.5  
(3.8, 27.4) 
24.4  
(7.9, 38.4) 
4.5  
(1.4, 10.1) 
0.9  
(0.1, 2.3) 
2.5  
(0.7, 6.4) 
10.6  
(3.6, 23.6) 
1.9  
(0.3, 13.2) 
7.6  
(2.8, 20.3) 
4.6  
(1.4, 7.6) 
0.6  
(0.1, 1.4) 
2.5  
(0.8, 4.5) 
97  
(56, 153) 
Other countries  
[139-143] 
62.0  
(46.6, 73.1) 
38.5  
(18.9, 60.6) 
49.9  
(34.6, 66.3) 
10.8  
(6.6, 15.2) 
3.4  
(1.1, 5.5) 
7.0  
(3.8, 10.3) 
22.6  
(12.9, 42.1) 
5.3  
(1.4, 16.3) 
16.1  
(8.7, 31.3) 
8.0  
(5.2, 9.1) 
1.9  
(0.9, 3.1) 
5.3  
(3.2, 5.7) 
378  
(158, 571) 
Global [186-190] 55.5  
(30.2, 70.4) 
32.0  
(11.8, 49.5) 
43.5  
(20.9, 60.9) 
9.8  
(4.4, 13.9) 
2.5  
(0.5, 4.9) 
6.5  
(2.5, 9.2) 
18.7  
(9.4, 40.9) 
3.7  
(0.8, 14.9) 
13.0  
(6.1, 30.6) 
7.8  
(3.5, 8.9) 
1.5  
(0.5, 2.9) 
4.9  
(2.0, 5.6) 
257  
(114, 524) 
Footnotes: 
Based on data from the WHO Global Information System on Alcohol and Health, with specific sources given below for each indicator. All data 
are median (first, third quartiles) values. 
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1 Countries allocated to geographic regions and group of least developed countries based on United Nations Statistics Division listing 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#ftnb). Numbers in square brackets indicate the number of countries in each 
grouping with data, showing the range for each indicator, or a single number if it was the same across all indicators. 
2 Proportion of adults (15+ years) who have consumed any alcohol during the past 12 months, by gender. Source: WHO Global Health 
Observatory, http://apps.who.int/gho/data/node.main.A1044?lang=en, accessed 28 November 2014. Country-level data are an average 
weighted by the respective populations. 
3 Total (recorded three-year average and unrecorded) adult (15+ years) per capita consumption, litres of pure alcohol per person per year. 
Data are an average of 2008-2010 estimates. Source: http://apps.who.int/gho/data/node.main.A1032?lang=en, accessed 28 November 
2014. 
4 Proportion of adult drinkers (15+ years) who have had at least 60 grams or more of pure alcohol on at least one occasion in the past 30 
days, by gender 
Source: http://apps.who.int/gho/data/node.main.A1047?lang=en, accessed 28 November 2014. County-level data are an average weighted 
by the population of respondents who consumed any alcohol during the past 12 months. 
5 Proportion of adults (15+ years) with alcohol use disorders during the past 12 months, by gender. Alcohol use disorders defined as harmful 
use of alcohol (ICD-10 F10.1) or alcohol dependence (ICD-10 F10.2). Country-level data are age standardised.  
Source: http://apps.who.int/gho/data/node.main.A1075?lang=en, accessed 28 November 2014. 
6 Age-standardised disability-adjusted life years (DALYs) for alcohol-use disorders, per 100,000 population 
Source: http://apps.who.int/gho/data/node.main.A1218?lang=en, accessed 28 November 2014. 
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Table 4: Tobacco smoking and related harms 
Region 
1
 
[Range of number 
of countries with 
data] 
Current smoking, adults, % 
2
 Current users of tobacco, youth 
population, % 
3
 
% deaths due to 
tobacco 
4
 
Male Female Both sexes Male Female Both sexes Male Female 
Africa [23-53] 23.0  
(16.0, 30.5) 
3.0  
(2.0, 5.0) 
13.0  
(9.5, 17.5) 
20.2  
(14.2, 26.3) 
11.5  
(8.1, 18.3) 
15.3  
(11.5, 23.0) 
4.0  
(3.0, 7.5) 
0  
(0, 2.0) 
Caribbean, Central 
& Northern 
America [11-23] 
20.0  
(13.0, 24.0) 
4.0  
(2.0, 8.0) 
13.0  
(8.0, 16.0) 
21.8  
(18.1, 25.3) 
15.6  
(12.8, 20.0) 
18.7  
(14.8, 23.7) 
8.0  
(4.0, 10.0) 
5.0 
(1.8, 8.0) 
South America  
[8-12] 
30.0  
(27.5, 39.3) 
14.5  
(6.5, 20.3) 
21.0  
(17.3, 28.8) 
25.0  
(21.0, 28.3) 
20.6  
(16.1, 29.2) 
22.1  
(19.3, 28.5) 
11.0  
(8.0, 15.0) 
5.0  
(2.0, 8.0) 
Central, Southern 
and Western Asia 
[23-28] 
37.0  
(31.0, 42.0) 
4.0  
(2.0, 9.0) 
23.0  
(16.0, 26.0) 
14.5  
(11.2, 25.2) 
8.1  
(4.3, 12.8) 
11.4  
(7.6, 18.6) 
15.0  
(12.3, 23.5) 
3.0  
(1.0, 8.0) 
Eastern and South-
Eastern Asia [12-14] 
45.0  
(39.0, 47.8) 
3.5  
(2.3, 6.8) 
23.5  
(22.0, 26.8) 
22.5  
(7.5, 31.7) 
7.5  
(4.0, 13.3) 
15.3  
(5.6, 22.6) 
19.5  
(16.8, 22.5) 
12.0  
(10.3, 15.8) 
Eastern Europe [10] 41.5  
(38.0, 49.3) 
22.0 
(13.3, 28.0) 
30.5  
(28.8, 36.8) 
28.2  
(24.7, 30.5) 
24.5  
(19.3, 31.7) 
27.1  
(23.1, 29.4) 
26.0  
(23.5, 28.5) 
5.5  
(3.5, 10.5) 
Northern Europe 
[3-10] 
28.0  
(23.5, 43.0) 
22.0  
(20.0, 25.5) 
27.0  
(23.0, 31.5) 
38.4  
(33.8, 41.8) 
28.8  
(27.8, 33.9) 
33.7  
(30.8, 37.6) 
22.0  
(16.0, 25.3) 
11.0  
(5.5, 20.3) 
Southern Europe 
[8-11] 
34.5  
(30.8, 44.5) 
24.0  
(17.3, 27.8) 
28.0  
(24.8, 33.5) 
16.6  
(11.1, 17.5) 
11.1  
(7.4, 21.8) 
12.6  
(10.8, 20.4) 
25.0  
(24.0, 27.0) 
7.0  
(3.0, 8.0) 
Western Europe  
[0-8] 
33.0  
(30.5, 40.8) 
24.0  
(22.8, 35.8) 
28.5  
(26.0, 38.5) 
NC NC NC 22.0  
(19.5, 27.3) 
8.5 
(5.8, 10.0) 
Oceania [9-15] 43.0  
(32.3, 52.8) 
19.0  
(11.0, 29.5) 
29.5  
(20.8, 43.5) 
34.1  
(22.3, 53.7) 
32.7  
(20.0, 40.1) 
35.1  
(21.8, 47.0) 
7.0  
(4.0, 13.0) 
8.5  
(5.0, 13.8) 
Least developed 
countries [27-47] 
25.0  
(16.0, 42.0) 
3.0  
(2.0, 7.0) 
14.0  
(10.0, 25.0) 
20.4  
(13.0, 26.4) 
11.6  
(7.4, 19.6) 
16.6  
(10.6, 23.2) 
4.0  
(3.0, 9.0) 
2.0  
(0, 8.0) 
Other countries 
[109-132] 
34.0  
(25.5, 43.0) 
9.0  
(3.0, 21.0) 
23.0  
(17.0, 29.0) 
21.5  
(15.0, 28.2) 
14.5  
(8.2, 22.2) 
18.1  
(12.0, 25.8) 
14.0  
(7.3, 23.0) 
6.0  
(3.0, 11.0) 
Global [136-179] 32.0  
(23.3, 43.0) 
7.0  
(3.0, 19.8) 
22.5 
(15.0, 27.0) 
20.9  
(14.5, 27.8) 
13.2  
(7.9, 21.5) 
17.6  
(11.8, 24.9) 
11.0  
(5.0, 22.0) 
6.0  
(2.0, 10.0) 
Footnotes: 
Based on data from the  WHO Global Health Observatory, with specific sources given 
below for each indicator. All data are median (first, third quartiles) values.  
1 Countries allocated to geographic regions and group of least developed countries based 
on United Nations Statistics Division listing 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#ftnb). Numbers in square 
brackets indicate the number of countries in each grouping with data, showing the range 
for each indicator, or a single number if it was the same across all indicators. NC 
indicates there were insufficient data for calculation of regional values (data available 
from less than 3 countries). 
2 Current smoking of any tobacco product, adults aged 15 years and over, age-
standardized rate, by gender. "Tobacco smoking" includes cigarettes, cigars, pipes or 
any other smoked tobacco products. “Current smoking” includes both daily and non-daily 
or occasional smoking. 
http://apps.who.int/gho/data/node.main.1250?lang=en, accessed 28 November 2014. 
3 Current users of any tobacco product, % of total youth population aged 13-15. Current 
users of any tobacco product are defined as those that consumed any smokeless or 
smoking tobacco product at least once during the last 30 days prior to the survey. 
http://apps.who.int/gho/data/node.main.1259?lang=en, accessed 28 November 2014.  
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4 Proportion of deaths in population aged 30 and over attributable to tobacco, by gender, 
estimated from 2004 mortality data. Detailed information on calculation of the mortality 
rates available from the WHO Global Report Mortality Attributable to Tobacco, available 
from http://whqlibdoc.who.int/publications/2012/9789241564434_eng.pdf?ua=1 
(accessed 28 November 2014); summary data also available from www.tobaccoatlas.org 
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Table 5: Unsanctioned psychoactive drug use1 and related harms 
Region 
2
 
[Range of number of 
countries with data] 
Cannabis 
3
 Opioid-type 
3
 Cocaine-type 
3
 Amphetamine-
type 
3
  
Ecstasy 
3
 HIV 
4
 Injecting 
5
 Prevalence in injecting 
drug users, % 
6
 
DALYs 
7
 Deaths per 
million 
adults
8
 
       HIV Hepatitis C   
Africa [1-51] 3.0  
(2.2, 6.0) 
0.2  
(0.1, 0.3) 
0.2  
(0, 0.7) 
0.5  
(0.1, 1.2) 
0.2  
(0, 0.3) 
2.1  
(1.0, 5.6) 
0.1  
(0, 0.7) 
8.2  
(6.2, 20.6) 
62.7  
(50.2, 94.5) 
71  
(67, 85) 
NC 
Caribbean, Central & 
Northern America [2-22] 
4.8  
(1.3, 8.4) 
0.2  
(0.1, 0.7) 
0.8  
(0.5, 1.1) 
0.8  
(0.4, 1.2) 
0.2  
(0.1, 0.3) 
0.7  
(0.3, 1.6) 
0.8  
(0.1, 1.2) 
6.2  
(5.8, 12.9) 
73.4  
(69.1, 96) 
125  
(76, 187) 
8.5  
(4.2, 132.7) 
South America [2-12] 3.6  
(1.6, 4.8) 
0.1  
(0, 0.3) 
0.7  
(0.3, 1.0) 
0.4  
(0.1, 0.5) 
0.1  
(0, 0.2) 
0.5  
(0.4, 0.7) 
0.3  
(0.2, 0.5) 
10.5  
(5.2, 14.3) 
NC 323  
(139, 368) 
3.2  
(2.2, 21.2) 
Central, Southern and 
Western Asia [6-26] 
3.2  
(2.2, 4.2) 
0.4  
(0.2, 1.4) 
0  
(0, 0.2) 
0.2  
(0.1, 0.4) 
0.4  
(0.2, 1.0) 
0.2  
(0.1, 0.3) 
0.2  
(0, 0.6) 
3.9 
(0.3, 9.5) 
40.0  
(24.0, 51.4) 
85  
(65, 255) 
8.5  
(2.5, 21.3) 
Eastern and South-
Eastern Asia [3-5] 
0.7  
(0.3, 1.1) 
0.2  
(0.1, 0.6) 
0  
(0, 0.1) 
0.4  
(0.2, 1.0) 
0.2  
(0.1, 0.3) 
0.4  
(0.2, 0.7) 
0.3  
(0, 0.5) 
13.4  
(8.7, 21.9) 
67.1  
(59.5, 77.1) 
78  
26, 138) 
22.6  
(21.8, 35.7) 
Eastern Europe [3-10] 3.2  
(1.0, 3.7) 
0.1  
(0.1, 0.7) 
0.2  
(0.1, 0.3) 
0.4  
(0.1, 0.7) 
0.5  
(0.2, 0.7) 
0.7  
(0.4, 0.9) 
0.5  
(0.3, 1.2) 
7.3  
(0.5, 18.0) 
47.8  
(22.6, 69.2) 
93  
(25, 237) 
13.9  
(5.9, 29.1) 
Northern Europe [0-12] 4.9  
(3.5, 6.0) 
0.6  
(0.3, 0.8) 
0.8  
(0.3, 1.5) 
0.8  
(0.5, 1.0) 
0.5  
(0.3, 1.2) 
NC 0.3  
(0.3, 0.8) 
3.4  
(1.9, 10.8) 
65.8  
(54.1, 73.0) 
91  
(59, 162) 
76.6  
(42.1, 113.9) 
Southern Europe [0-13] 2.9  
(1.7, 4.3) 
0.4  
(0.3, 0.5) 
0.5  
(0.3, 0.7) 
0.3  
(0.1, 0.7) 
0.6  
(0.3, 0.8) 
NC 0.2  
(0.1, 0.4) 
1.4  
(0.4, 9.1) 
36.5  
(28.7, 51.9) 
149  
(116, 232) 
15.5  
(6.9, 30.8) 
Western Europe [0-9] 5.2  
(4.8, 7.0) 
0.3  
(0.2, 0.5) 
0.9  
(0.8, 1.0) 
0.5  
(0.2, 0.7) 
0.5  
(0.3, 0.9) 
NC 0.3  
(0.2, 0.6) 
4.2  
(1.9, 7.2) 
58.7  
(41.4, 63.8) 
162  
(99, 205) 
17.0  
(3.2, 23.2) 
Oceania [2-14] 10.3  
(5.1, 14.6) 
NC NC NC NC NC NC NC NC 36  
(32, 39) 
NC 
Least developed countries 
[2-45] 
3.2  
(1.5, 4.3) 
0.2  
(0.1, 0.4) 
NC 0.2  
(0.1, 1.0) 
0.2  
(0.1. 0.3) 
1.2  
(0.5, 2.8) 
0  
(0, 0.2) 
7.1  
(6.3, 22.5) 
49.8  
(36.9, 80.5) 
70  
(66, 84) 
NC 
Other countries [65-136] 3.5  
(1.6, 5.3) 
0.3  
(0.1, 0.6) 
0.5  
(0.2, 0.9) 
0.5  
(0.2, 0.8) 
0.3  
(0.1, 0.6) 
0.5  
(0.3, 1.4) 
0.3  
(0.1, 0.6) 
5.9  
(1.4, 12.2) 
52.6  
(36.5, 67.9) 
100  
(62, 213) 
17.9  
(5.3, 41.1) 
Global [72-181] 3.5  
(1.6, 5.2) 
0.2  
(0.1, 0.6) 
0.5  
(0.2, 0.9) 
0.5  
(0.2, 0.8) 
0.3  
(0.1, 0.5) 
0.7  
(0.3, 2.1) 
0.3  
(0.1, 0.5) 
6.3  
(1.8, 12.5) 
52.6  
(36.5, 67.9) 
83  
(63, 173) 
17.3  
(5.7, 40.8) 
Footnotes: 
Based on data from the  World Drug Report and WHO Global Health Observatory, with specific sources given below for each indicator. All data are 
median (first, third quartiles) values.  
1 Unsanctioned psychoactive drug use refers to the use of psychoactive drugs whose possession and/or supply is illegal in most jurisdictions or prescription 
opioids that are being used in an unsanctioned way. 
2 Countries allocated to geographic regions and group of least developed countries based on United Nations Statistics Division listing 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#ftnb). Numbers in square brackets indicate the number of countries in each grouping with data, 
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showing the range for each indicator, or a single number if it was the same across all indicators. NC indicates there were insufficient data for calculation of 
regional values (data available from less than 3 countries). 
3 Annual prevalence of use of unsanctioned drug use, by type, as a percentage of the population aged 15-64 (but with some minor variation of age range 
between countries). Dates of estimated prevalence range from 2002 to 2012. “Unsanctioned” drug use includes use of illicit drugs and use of 
pharmaceutical preparations for non-medical purposes or other than as prescribed. “Opioids” includes illicit preparations of opiates (heroin, opium) and 
non-medical use of prescription opioid drugs. http://www.unodc.org/wdr2014/, accessed 27 June 2014. 
4 Prevalence of HIV among adults aged 15 to 49, % of population in that age group, 2012 estimates. 
http://apps.who.int/gho/data/node.main.622?lang=en , accessed 28 November 2014 
5 Prevalence of injecting drug use among adults aged 15-64, %. Dates of estimates range from 1996 to 2012.  
http://www.unodc.org/wdr2014/, accessed 27 June 2014. 
6 Prevalence of HIV and Hepatitis C amongst injecting drug users, %. Dates of HIV estimates range from 1997 to 2012, dates of hepatitis C estimates range 
from 2003 to 2011. http://www.unodc.org/wdr2014/, accessed 27 June 2014. 
7 Age-standardised disability-adjusted life years (DALYs) for drug-use disorders, per 100,000 population 
Source: http://apps.who.int/gho/data/node.main.A1218?lang=en, accessed 28 November 2014. 
8 Drug-related mortality per million population aged 15-64. Dates of estimates range from 2002 to 2012. 
http://www.unodc.org/wdr2014/, accessed 27 June 2014. 
24 
 
Table 6: Prevalence of gambling by country1 
 Year Age % 
Past 
year2 
% 
Problem 
gambling3 
Australia 1999 18+ 82 3.9 
Belgium 2006 16-99 59.7 2.8 
Brazil 2005-2006 14+   0.9 
Canada 2006-2007 18+ 70.7 2 
Cyprus [Northern] 2007 18-65 55 2.2 
Czech Republic 2012? 15-64 60   
Denmark 2005 18-74 77 0.5 
Estonia 2006 15-74 75 2.1 
Finland 2011-2012 15-74 78 1.5 
France 2009-2010 18-75 47.8 1.1 
Germany 2011 18+ 63.5 0.8 
Great Britain 2006-2007 16+ 68 0.7 
Hong Kong 2011 15-64 62 4.4 
Hungary 2007 18-64 65.3 1 
Iceland 2007 18-70 69.4 1 
Isle of Man 2012 16+ 78   
Italy 2008 18-74 54 2.3 
Lithuania 2006 18-64 30.1 2.1 
Macau 2003 15-64 67.9 6 
Netherlands 2004 16+ 71.7 0.5 
New Zealand 2006-2007 15+ 65.3 1 
Northern Ireland 2010 16+ 75.3 3.3 
Norway 2010 15-70+   1.4 
Singapore 2011 18+ 47 3.1 
South Africa 2008 18+ 52.1 6.4 
South Korea 2011 19+ 41.8 0.8 
Sweden 2008-2009 16-84 70 1.5 
Switzerland 2006-2007 14+ 34.4 0.4 
United States 2001-2003 18+ 78.4 1.5 
Footnotes: 
1 The data included in this table are generally the most recent available for each country, 
with year indicating the time of assessment. Where data were available for a particular 
country from multiple years, in some instances the data was selected on the basis of sample 
size rather than most recent data. Source: Alberta Gambling Research Institute: 
http://www.abgamblinginstitute.ualberta.ca/LibraryResources/ReferenceSources/PrevalenceI
nternational.aspx 
2 Prevalence of any gambling (excluding raffles) in past year (% of population) 
3 Standardised problem gambling prevalence (% of population) 
 
 
